Rosiglitazone for type 2 diabetes mellitus

被引：0

|

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1999年 / 41卷 / 1059期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：71 / +

页数：3

相关论文

共 50 条

[11] Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
Malinowski, JM
Bolesta, S
CLINICAL THERAPEUTICS, 2000, 22 (10) : 1151 - 1168
[12] Rosiglitazone in the management of older patients with type 2 diabetes mellitus
Kreider, M
Heise, M
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (07) : 538 - 541
[13] The use of a combination of metformin and rosiglitazone in type 2 diabetes mellitus
Demidova, T. Y.
DIABETES MELLITUS, 2007, 10 (03): : 27 - 31
[14] Rosiglitazone monotherapy for type 2 diabetes mellitus—too soon to ADOPT?
Peter Gæde
Oluf Pedersen
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 456 - 457
[15] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus Reply
Zinman, Bernard
LANCET, 2010, 376 (9750): : 1388 - 1388
[16] Rosiglitazone - A review of its use in the management of type 2 diabetes mellitus
Wagstaff, AJ
Goa, KL
DRUGS, 2002, 62 (12) : 1805 - 1837
[17] The effect of rosiglitazone in overweight type 1 diabetes mellitus
Strowig, SM
Raskin, P
DIABETES, 2004, 53 : A147 - A147
[18] Once-daily rosiglitazone is effective in the treatment of type 2 diabetes mellitus
Nolan, JJ
Jones, NP
Patwardhan, R
Deacon, LF
DIABETES, 1999, 48 : A111 - A111
[19] Rosiglitazone monotherapy for type 2 diabetes mellitus -: too soon to ADOPT?: Commentary
Gaede, Peter
Pedersen, Oluf
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 456 - 457
[20] Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus
Vrablik, Michal
Dobiasova, Milada
Stulc, Tomas
Kasalova, Zdislava
Dolezalova, Radka
Prazny, Martin
Fait, Tomas
Ceska, Richard
NEUROENDOCRINOLOGY LETTERS, 2008, 29 (01) : 146 - 150

← 1 2 3 4 5 →